Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...

Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian ...

A recent CDC study said greater access to fertility treatments and more education for teens have led to a role reversal in ...

Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's ...

Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!

The company plans to introduce Beyfortus, which contains the monoclonal antibody, nirsevimab, in a prefilled injection used ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used ...

Hyderabad gastroenterologist D. Nageshwar Reddy awarded Padma Vibhushan for medical contributions by President Murmu.

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian arm, Sanofi Healthcare India Pvt Ltd (SHIPL), to bring a ...

Dr. Reddy’s Laboratories will expand its partnership with Sanofi Healthcare India (SHIPL) by launching the latter’s novel drug Beyfortus (nirsevimab) in India.

Within three years, Apollo became profitable. Dr. Reddy then established hospitals in cities like Ahmedabad, Bilaspur, Mysore ...